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Abstract
Many women with Polycystic Ovary Syndrome (PCOS) report high depression rates. The
relationship between PCOS and these high depression rates is unclear. Two-component
lifestyle interventions have revealed short-term effects on depression scores in this group of
women. In general, 3-component interventions including diet, exercise, and cognitive
behavioral therapy (CBT) are more effective in the long-term to improve emotional well-
being. This has not yet been studied in women with PCOS. This study examined the effect
of 20 CBT lifestyle (LS) sessions combined with a healthy diet and physical therapy with or
without 9 months additional feedback through Short Message Service (SMS) via mobile
phone, compared to care as usual (CAU, involving advice to lose weight). In this secondary
analysis, 155 women with PCOS and a BMI above 25 kg/m2 were eligible. Depression
scores decreased significantly in the LS programme compared to CAU (P = 0.045). In both
the LS programme without SMS (P = 0.036) and the LS programme with SMS (P = 0.011)
depression scores decreased while no change was observed in CAU (P = 0.875). Self-
esteem scores improved significantly in the LS programme compared to CAU (P = 0.027).
No differences in body image scores were observed in LS participants compared to CAU (P
= 0.087), although body image improved significantly in both the LS without SMS (P =
0.001) and with SMS (P = 0.008) study arms. We found no significant mediating role by
androgens in the relationship between LS participants and emotional well-being. Only
weight-loss mediated the relationship between LS and self-esteem. To conclude, a three-
component lifestyle intervention programme with or without additional SMS resulted in sig-
nificant improvements in depression and self-esteem compared to CAU, in women with
PCOS, obesity, and a wish to achieve a pregnancy. Testosterone, androstenedione, DHEA,
insulin, HOMA-IR, and cortisol did not mediate this effect. Weight loss mediated the effects
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on self-esteem but not on depression and body-image. This suggests that lifestyle treatment
independent of weight loss can reduce depression and body-image, but both lifestyle treat-
ment and weight loss can improve self-esteem. Thus, a three-component lifestyle interven-
tion based on CBT could prove successful in improving mood in women with PCOS who are
overweight or obese and attempting to become pregnant.
Introduction
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder that affects 8–15% of
women in their reproductive years [1–3]. The diagnosis of PCOS requires at least two of the
following three criteria: (i) oligo-ovulation or anovulation (irregular or no menstrual cycle),
(ii) clinical hyperandrogenism (hirsutism) and/or biochemical signs of hyperandrogenism
(elevated free androgen index or elevated testosterone levels), (iii) polycystic ovarian morphol-
ogy (by transvaginal ultrasound), and the exclusion of other etiologies that might cause hyper-
androgenism [4]. Most women with PCOS experience one or more of the following physical
symptoms in varying degrees: hirsutism (excessive body hair growth), acne, infertility, obesity,
insulin resistance and dyslipidemia [5, 6].
Women with PCOS experience more depressive and anxiety complaints, have lower self-
esteem, and experience a more negative body image compared to women without PCOS [7–
9]. In particular, depression scores are significantly higher [7, 10] and seem to be consistently
elevated throughout the lifespan of women with PCOS compared to controls [11]. A recent
meta-analysis of depression rates among women with PCOS resulted in a median prevalence
of depression of almost 37% compared to 14% in controls [8]. Hence, the recent international
guideline on PCOS states that depressive and anxiety symptoms should be screened, assessed
and managed with the requirement for awareness of emotional wellbeing [12] Women with
PCOS and BMI� 30 kg/m2 have significantly higher depression rates compared to women
with PCOS and a healthy BMI [10]. A 5% to 10% weight loss improves many PCOS features,
including psychological factors [13, 14]. It is unclear how these psychological improvements
are generated and whether these psychological improvements are sustained in the long-term.
One of the first lifestyle (LS) interventions in women with PCOS was developed by Clark and
colleagues. This involved 6 months of seminars covering weight-related topics and resulted in
significantly lower depression scores, although no control group was used [15, 16]. Thompson
and colleagues developed a 20-week diet and exercise intervention and found significant
improvements with respect to depression during the first 10 weeks of the intervention. It is
unclear why depression scores did not improve after 10 weeks as participants continued their
weight loss and PCOS symptoms improved [17]. A more recent paper demonstrated that a
16-week LS intervention programme resulted in better quality of life [18]. This LS intervention
included behavioral modification strategies, although these specific strategies were not
described [19]. Others found improvements in depression, health-related quality of life and
self-esteem during a high-protein and low-carbohydrate diet, but not in the amount of weight
loss [20, 21].
In the general population there is a bidirectional association between obesity and the odds
of depression [22]. In women with PCOS the results are inconclusive: some authors concluded
that women with PCOS and a higher BMI are more depressed, while others suggest the oppo-
site. Women with PCOS still have higher odds for depressive and anxiety symptoms when
matched for BMI [8]. A recent review presented potential mechanisms other than obesity for
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the increased depression risk in women with PCOS. Insulin resistance, increased testosterone
levels, higher hirsutism scores measured by the modified Ferriman-Gallwey questionnaire,
infertility due to oligo-ovulation, increased corticotrophin-releasing hormone, increased corti-
sol, markers of inflammation, low vitamin D status [23], and elevated Homeostatic Model
Assessment for Insulin Resistance (HOMA-IR) levels [24], may contribute to the association
between PCOS and depression. Despite the evidence that women with PCOS have increased
odds for depression and anxiety, there is no evidence supporting a single etiology for this
increased prevalence of depression and anxiety [23]. Thus it remains unclear whether depres-
sion is related to one of the above mechanisms and if depression rates could change through
weight loss.
The first-line treatment for depression is cognitive behavioral therapy (CBT) and, depend-
ing on the setting, can be combined with antidepressant treatment [25]. In the general popula-
tion, long-term results are mixed; some meta-analysis found CBT to be equally effective
compared to other psychological treatments while other meta-analysis found favorable results
for CBT [26]. Little research has been undertaken concerning CBT among women with PCOS.
A pilot study demonstrated that 8 weeks of 30 minutes’ CBT combined with 30 minutes’ LS
sessions resulted in a significant improvement in quality of life but no improvements in
depression scores were observed [27]. A recent randomized control trial (RCT) showed that 8
CBT group sessions of 45 to 60 minutes was effective for psychological fatigue and quality of
life [28]. In the new PCOS guideline there is no referral to a specific treatment for depression
in women with PCOS, and the advice is to follow regional clinical guidelines [12].
In conclusion, previous studies covered study periods of 24 weeks at most, were not ran-
domized controlled trials, had small sample sizes, and did not use a structured CBT protocol.
Hence, we investigated whether a CBT programme for women with PCOS who were over-
weight and obese achieved weight loss in the long-term in a large sample. The aim of this sec-
ondary analysis was to compare the changes in depression scores in a three-component CBT
LS intervention (with or without SMS), with these scores in the control group. In addition, the
effectiveness of additional SMS on self-esteem and body image was examined. We hypothe-
sized that there is an interaction of androgens (testosterone, androstenedione and dehydro-
epiandrosterone (DHEA)), insulin, HOMA-IR, and cortisol, on well-being scores in women
with PCOS. Hence, we tested whether the relationship between lifestyle treatment and well-
being is mediated by changes in androgens (testosterone, androstenedione and DHEA), insu-
lin, HOMA-IR, and cortisol.
Methods
Patients
Women were eligible if they were diagnosed with PCOS according to the Rotterdam 2003 con-
sensus criteria, had a BMI above 25 kg/m2, were between 18 and 38 years old, and attempting
to become pregnant. Women with inadequate command of the Dutch language, severe mental
illness, obesity with another somatic cause, ovarian tumors that lead to an androgen excess,
adrenal diseases, had other malformations of their internal genitalia, or those that were preg-
nant, were not eligible for the study. Participants did not receive any fertility treatment during
the study period.
Study design
This study was approved by the Medical Research Ethics Committee of the Erasmus MC in
Rotterdam; reference number MEC 2008–337. The study protocol can be found at http://dx.
doi.org/10.17504/protocols.io.bfq9jmz6. The current study on emotional well-being represents
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a secondary analysis. At baseline, 183 participants were randomized at a 1:1:1 ratio using a com-
puter-generated random numbers table into three arms: 1) 1-year CBT LS intervention provided
by a multidisciplinary team, or 2) 1-year CBT LS intervention provided by a multidisciplinary
team extended with a Short Message Service (SMS,) or 3) care as usual (CAU): encouragement
to lose weight by publicly available services (i.e. diets, visiting a dietician, going to the gym, or
participating in public programmes such as Weight Watchers1). The 1-year multidisciplinary
LS intervention aimed at: 1) changing cognitions, 2) changing dietary habits, 3) encouraging and
promoting physical activity, and 4) activating social support. It consisted of 20 group sessions of
2.5 hours over one year. During all sessions, CBT techniques were used to create awareness and
to restructure dysfunctional thoughts about lifestyle (food and exercise), weight (loss) and self-
esteem. More details about the intervention and an overview of the content of each session can
be found in the study protocol [29]. Additional to the lifestyle programme, participants in the
SMS group sent weekly self-monitored information regarding their diet, physical activity, and
emotions by SMS to the psychologist. Subsequently, they received feedback on their messages to
provide social support, encourage positive behavior, and empower behavioral strategies.
Outcome measures
At baseline, and at 3-, 6-, 9- and 12-months, participants attended the outpatient clinic for a
standardized screening. This screening included a family and reproductive history, and a phys-
ical examination assessing anthropometric and ultra-sonographic features of the syndrome.
The primary outcome of the RCT (weight) was also measured. Participants also completed
questionnaires on well-being at these time points.
Well-being was measured using three instruments: depression with the Beck Depression
Inventory-II (BDI-II), self-esteem with the Rosenberg Self Esteem Scale (RSES), and body
image with the Fear of Negative Appearance Evaluation Scale (FNAES).
BDI-II is a validated and widely-used questionnaire in depression trials assessing the sever-
ity of depressive symptoms over the previous 2 weeks, according to the DSM-IV criteria. It is a
21-item self-report questionnaire with items rated on a 4-point scale (0–3) and summed to
give a total score (range 0–63). A higher score on the BDI-II denotes more severe depression.
In non-clinical populations, scores above 20 indicate depression [30]. More specifically: scores
of 0–13 indicate minimal depression, 14–19 (mild depression), 20–28 (moderate depression),
and 29–63 (severe depression) [31]. The National Institute for Health and Care Excellence
(NICE) suggested a difference of�3 BDI-II points as a clinically significant effect for normal
depression [32]. A recent study estimated a minimal clinically important difference (MCID)
for the BDI-II of a 17.5% reduction from baseline [33].
Global self-esteem and self-acceptance was measured by the RSES [34]. This questionnaire
consists of 10 questions (5 positive and 5 negative) and has been validated for the Dutch popu-
lation [35]. Items are rated on a 4-point Likert scale and total scores range from 0 to 30, where
a higher score indicates higher levels of self-esteem. There are no official cut-offs, although
scores between 15 to 25 are considered as normal self-esteem and scores below 15 as low self-
esteem in women with PCOS [36].
The brief version of the FNAES [37] is a short questionnaire consisting of 6 items that mea-
sure body image, eating attitude, and depression. The items are answered on a 5-point Likert
scale, ranging from ‘not at all’ to ‘extremely’, where a higher score indicates more fear of nega-
tive evaluation by others (range 6–30). We used a translated version of the FNAES, which has
been used before in PCOS [38].
All participants underwent 5 similar standardized measurements during the study period.
During these measurements blood samples were collected between 8.00 and 11.00 a.m. after
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overnight fasting. Levels of serum testosterone, androstenedione, DHEA, and cortisol were
measured with RIA (Siemens) until 2012. After 2012, liquid chromatography-tandem mass
spectrometry (LC-MS/MS) was used. Homeostatic assessment of insulin resistance
(HOMA-IR) was calculated from fasting insulin and glucose by the following equation:
HOMA-IR = (fasting glucose (mg/dl) � fasting insulin (μIU/ml)) / 405 [39].
Analyses
The power calculation was based on the primary outcome of the lifestyle intervention: weight
(kg). The method described by Aberson [25] was applied, with a power of 0.90, a 2-sided alpha
of 0.025 (corrected for the interim analysis as described in the study protocol), and 5 repeated
measures linearly decreasing. We observed an intercorrelation of around 0.90 between all mea-
surements. With a ratio of 1:1:1, the required sample was 42 in each group. With an expected
drop-out proportion of 40% [40], 60 participants in each group were needed for the study.
Descriptive statistics were used to characterize depression, self-esteem, and body image in
this sample. Normality of the distributions was checked with Shapiro-Wilks tests. Multilevel
regression models were applied for longitudinal analyses of depression (BDI-II), self-esteem
(RSES), and body image (FNAES) scores. Mixed modeling can deal efficiently with missing
data and unbalanced time-points [41]. This means that, additionally, patients without com-
plete follow-ups could be included in the analyses, without imputation. This method also com-
pensates for selective dropout, on the condition that dropout is related to variables included in
the models. The analysis included 2 levels; the patients constituted the upper level and their
repeated measures the lower level. The difference from ordinary linear regression is that this
analysis takes into consideration that measurements belong to a given participant. The devi-
ance statistic [42] using restricted maximum likelihood [43] was applied to determine the
covariance structure, thus taking into account the situation when, e.g., the deviation at baseline
was different from the deviations at follow-ups. The covariance structure was determined with
deviance tests, using restricted maximum likelihood. To this end, the unstructured compo-
nent, the variance component and the intercept- only covariance structures were compared
amongst each other. In the case of a non-normal distribution a bootstrap procedure with
10,000 samples was performed to obtain reliable standard errors and p-values. Study group,
linear and logarithmic time and interactions were included as independent variables. Cohen’s
d effect sizes were calculated by performing additional multilevel models on normalized out-
come measures, using Blom transformations [44]. Blom transformations have the characteris-
tic that they are standardized, thus the outcomes are Cohen’s d effect sizes. Cohen valued
d = 0.2 as a ’small’ effect size, 0.5 as a ’medium’ effect size and 0.8 as a ’large’ effect size [45]. To
test if androgens, insulin, HOMA-IR, and cortisol mediated the effect of LS intervention with
or without SMS on emotional well-being, we used multilevel longitudinal mediation or indi-
rect effect analyses. Paths α, β, τ and τ0 were estimated employing multilevel regression analy-
ses. Firstly, we determined whether paths β were significant. When path β was not significant,
mediation was improbable. We adjusted the Sobel-Goodman test for the indirect effect of the
independent variable on the dependent variable as reported by MacKinnon and Dwyer [46],
following the recommendations by Krull and MacKinnon [47] for multilevel mediation analy-
ses. The significance of the mediated effect is given by [48]:
Zmediation ¼
ab
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
b
2SE2
a
þ a2SE2b þ SE2aSE2b
q
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All analyses were performed utilizing IBM Corp (Released 2017. IBM SPSS Statistics for
Windows, Version 25.0. Armonk, NY: IBM Corp).
Results
Between August 2nd 2010 and March 11th 2016, 561 eligible women were asked to participate
and 209 provided written informed consent, of whom 26 were included in a pilot study. The
total sample for this secondary analysis consisted of 140 women who completed the depression
questionnaire, 155 who completed the body image questionnaire, and 141 who completed the
self-esteem questionnaire, all at baseline (Fig 1 and Table 1). According to the Shapiro-Wilks
test none of the baseline outcome variables were normally distributed. For all mixed models
linear time was not significant, thus superfluous. The logarithm of time was included in all the
models. The multilevel models are presented in S1 Table.
Depression
For depression a variance component covariance structure was found to be optimal (S2
Table). Depression scores decreased significantly in the LS intervention compared to CAU
(Cohen’s d = -0.34; p = 0.045). We observed no difference between LS with SMS and LS with-
out SMS (Cohen’s d = -0.02; p = 0.939), Table 2 and Fig 2. Over the study period, depression
scores decreased in LS without SMS by 3.7 points (Cohen’s d = -0.35; p = 0.036) and in the LS
with SMS by 3.8 points (d = -0.37; p = 0.011). The decrease in LS with and without SMS is con-
sidered clinically significant, and both LS groups reached the MCID threshold of a more than
17.5% reduction from baseline. Within the CAU group no change in depression scores was
observed (d = -0.02; p = 0.875, Table 3).
Self-esteem
It was also the case that for self-esteem a variance component covariance structure was found
to be optimal. Self-esteem scores improved significantly in the LS intervention compared to
CAU (Cohen’s d = 0.48; p = 0.027, Table 3 and Fig 3). We observed no beneficial effect for
additional SMS during lifestyle treatment (Cohen’s d = -0.07; p = 0.759). Self-esteem scores
improved in the LS intervention without SMS by 2.6 points (Cohen’s d = -0.44; p<0.001), and
in the LS with SMS by 2.2 points (d = -0.36; p = 0.002). Self-esteem scores remained virtually
stable within the CAU group (d = -0.02; p = 0.688), Fig 3.
Body image
For body image self-esteem an intercept only covariance structure was found to be optimal.
We observed no difference for LS intervention compared to CAU (Cohen’s d = -0.37;
p = 0.087), see Table 3. Although body image scores did improve significantly within the LS
intervention without SMS (d = -0.50; p = 0.001) and in LS with SMS (d = -0.47; p = 0.008). The
improvement within the CAU group of d = -0.12 was not statistically significant (p = 0.447),
Table 2 and Fig 4.
Mediation
We tested 21 different paths β: the relationship between LS intervention and the 3 outcome
measures (depression, self-esteem, and body image) with 7 potential mediators (testosterone,
androstenedione, DHEA, insulin, HOMA-IR, cortisol, and weight loss), Fig 5. Only 4 paths β
out of 21 turned out to be statistically significant with self-esteem; weight loss, androstenedi-
one, testosterone, and DHEA. No significant paths were observed for insulin, HOMA-IR, and
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cortisol. Consequently, there was no mediation by insulin, HOMA-IR and cortisol. Notably,
none of the paths with depression turned out to be statistically significant. When the potential
mediators with statistical significant paths β were used, mediation was not found in either the
relationship between LS (p = 0.613) and self-esteem with androstenedione, between LS with
self-esteem and testosterone (p = 0.834), nor between LS with self-esteem and DHEA
(p = 0.737). We also tested if weight loss mediated the effects on depression, self-esteem, and
body image. First, we examined weight loss in all groups. In CAU, participants lost 2.32 kg,
4.65 kg in LS without SMS and 7.87 kg in LS with SMS (within all groups P<0.001). Second,
we examined mediation in all three well-being outcomes. We found a nearly significant
Fig 1. Consort flowchart. BDI-II = depression, RSES = self-esteem, FNAES = body image.
https://doi.org/10.1371/journal.pone.0233876.g001
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(p = 0.08) relationship between weight loss and self-esteem. In other words, weight loss had a
nearly significant effect on the treatment-related changes in self-esteem. Weight loss appeared
to be a strong mechanism by which the intervention improved self-esteem. Weight loss had no
effect on the relationship between lifestyle treatment and improvements in depression or
body-image.
Discussion
This study is the largest RCT investigating weight loss during a three-component CBT lifestyle
intervention, and also the first to investigate long-term effects. All previous studies were LS
interventions that lasted between 10 and 24 weeks [15–18, 49] and did not examine well-being
in the long-term. We thus performed a secondary analysis of the well-being data that was
Table 1. Baseline characteristics by trial group. IQR = Interquartile range, BDI-II = depression, RSES = self-esteem, FNAES = body image. Spontaneous pregnancies
observed during the study period.
Control (CAU) Lifestyle without SMS Lifestyle with SMS
Median [IQR] Median [IQR] Median [IQR]
BDI-II scores 11.0 [5.0–18.0] 13.5 [5.9–24.0] 12.0 [5.5–20.9]
RSES scores 23.0 [17.5–26.0] 20.0 [14.0–23.0] 20.0 [16.0–24.7]
FNAES scores 15.0 [8.0–21.5] 20.5 [13.3–23.8] 19.0 [12.0–23.3]
Age (year) 28.0 [26.0–32.0] 30.0 [27.0–33.0] 28.0 [26.0–32.0]
Attempting to conceive (months) 27.5 [15.0–59.0] 27.0 [16.0–63.5] 24.5 [11.8–36.3]
Weight (kg) 84.0 [79.0–97.3] 89.0 [80.0–103.5] 94.5 [85.3–105.8]
Height (cm) 165 [160–170] 164 [160–169] 167 [161–170]
BMI (kg/m2) 30.6 [29.3–34.3] 33.5 [30.4–36.0] 33.5 [30.9–37.1]
Waist (cm) 96 [89–109] 100 [93–107] 102 [94–110]
Hip (cm) 114 [107–122] 116 [109–124] 120 [113–129]
Waist-Hip ratio 0.84 [0.80–0.90] 0.87 [0.81–0.90] 0.84 [0.80–0.90]
Modified Ferriman–Gallwey score 3 [1–6] 4 [2–9] 3 [1–9]
Testosterone 1.48 [1.10–2.00] 1.55 [1.20–2.20] 1.49 [0.99–2.00]
Androstenedione 8.8 [5.7–13.8] 7.7 [5.3–11.0] 8.5 [5.0–13.4]
Dehydro-epiandrosterone (DHEA) 24.9 [19.1–44.2] 21.2 [14.3–27.9] 21.6 [15.2–34.9]
Insulin 88.5 [62.0–122.5] 102.5 [54.0–147.5] 87.0 [50.5–122.0]
HOMA-IR 1.10 [0.77–1.57] 1.26 [0.68–2.01] 1.10 [0.67–1.65]
Cortisol 309 [248–366] 262 [220–334] 323 [237–385]
N (%) N (%) N (%)
Menstrual cycle
Oligomenorrhea 40 (88.9) 36 (80.0) 33 (70.2)
Amenorrhea 4 (8.9) 7 (15.6) 12 (25.5)
Regular 1 (2.2) 2 (4.4) 2 (4.3)
Spontaneous pregnancies 10 (16.7) 16 (26.7) 14 (23.3)
Hirsutism 11 (23.9) 16 (35.6) 14 (28.6)
Caucasian 14 (30.4) 17 (37.8) 24 (49)
Education
Low 5 (20.0) 1 (3.4) 2 (6.1)
Intermediate 15 (60.0) 16 (55.2) 20 (60.6)
High 5 (20.0) 12 (41.4) 11 (33.3)
History of depression 0 (0.0) 0 (0.0) 4 (8.2)
BDI-II > 13 19 (41.3) 22 (50.0) 21 (42.9)
BDI-II > 20 9 (19.6) 16 (36.4) 13 (27.1)
https://doi.org/10.1371/journal.pone.0233876.t001
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collected in the RCT. We observed positive effects of LS treatment on depression scores during
the entire 12 months intervention period. Others only observed short term effects that lasted
for 10 weeks [17]. As discussed in the Introduction, some researchers have suggested that
women with PCOS appear to have a unique risk for depression [8] that is persistent over time
[11, 50], which could either be related to the condition itself, or to: weight, androgens, insulin,
cortisol [22]. Hence we tested the potential mediation of androgens, insulin, HOMA-IR, and
cortisol in the relationship between LS treatment and emotional well-being. Surprisingly, we
found neither mediation by androgens nor by insulin, HOMA-IR, or cortisol. A nearly signifi-
cant relationship was found between LS treatment and self-esteem mediated by weight loss,
suggesting that the effects on self-esteem were caused by changes in weight loss. Our results
suggest that the three-component intervention was the determining factor with respect to the
improvements in depression and body-image, and that improvements in self-esteem were
mediated by weight loss.
Compared to other LS interventions performed in women with PCOS [15, 16, 18], our
intervention was the only one that was CBT-based. Previous interventions involved seminars
covering weight-related topics [16, 49] or behavioral modification strategies [18]. Comparing
our intervention to others is difficult because there are large differences in treatment protocols
or information is lacking on which behavioral strategies are used. To optimize future research
and promote treatment adherence, we used a standardized CBT protocol for all 20 sessions.
During every therapy session a given topic was discussed, and the specific CBT techniques for
that session were described in the study protocol [29].
In addition to the significant decline in depression scores, we also observed a clinically sig-
nificant decline of�3 points [32] and a minimal clinically important difference (MCID) of
more than the threshold of 17.5% [33] in LS interventions with and without SMS. The MCID
is the optimal threshold above which individuals report feeling ‘better’. In other words, the
three-component LS intervention improved depression rates while no changes in depression
rates during CAU were observed. Little is known about the possible mechanism through
which LS interventions achieve their effects or which components contributed the most [51].
Due to the design of our study we do not know if 1 or 2 of the 3 components (diet, exercise,
CBT), or the 3 components as a whole, affected emotional well-being.
Participants in our study had lower mean self-esteem and lower body image scores com-
pared to a previous study in women with PCOS [38]. This difference could be explained by
Table 2. Difference in depression, self-esteem and body image changes between study groups at 12 months. The
difference in depression, self-esteem and body image scores over time compared between lifestyle and care as usual
and compared between lifestyle with SMS and without SMS. Cohen’s D 0.20 is small effect, 0.50 is medium effect and
0.80 a large effect, BDI-II = depression, RSES = self-esteem, FNAES = body image.
Lifestyle vs Care as Usual Lifestyle with SMS vs. Lifestyle without SMS
Estimate Estimate
BDI-II difference -3.44 -1.19
Cohen’s d -0.41 0.04
P value 0.045 0.628
RSES difference 2.65 -0.24
Cohen’s d 0.46 -0.04
P value 0.003 0.823
FNAES difference -2.60 0.63
Cohen’s d -0.29 0.13
P value 0.094 0.756
https://doi.org/10.1371/journal.pone.0233876.t002
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BMI because our study population was more obese. As shown in the mediation analysis,
weight loss mediated treatment effects on self-esteem, while this was not the case for the
changes in depression and body-image during LS treatment. This result is in line with a meta-
analysis of well-being outcomes in weight loss treatments. Only treatments that produced
actual weight loss showed increased self-esteem, whereas improvements in depression were
independent of weight loss. This indicates that self-esteem and depression are different con-
structs [52]. The improvements in body-image could be caused by the combination of CBT
and group treatment, where group cohesion and social support might have played an impor-
tant role. Many participants mentioned that the LS programme helped them to realize that
they ‘were not alone’, emphasizing that PCOS and obesity made them feel lonely and insecure.
It is known that group cohesion and social support can be strong in small groups [53] and
Fig 2. Depression scores over time.
https://doi.org/10.1371/journal.pone.0233876.g002
Table 3. Estimated depression, self-esteem and body image scores over time. Cohen’s D: 0.20 = small effect, 0.50 = medium effect and 0.80 = a large effect.
Group Baseline 12 months Change baseline—12 months
Estimate Estimate Estimate Percent Cohen’s d P value
Depression (BDI-II) Care as usual (CAU) 13.3 13.1 -0.2 -1.5% -0.02 0.875
Lifestyle without SMS 15.5 11.9 -3.7 -23.6% -0.35 0.036
Lifestyle with SMS 13.2 9.4 -3.8 -29.0% -0.37 0.011
Self-esteem (RSES) Care as usual (CAU) 21.2 20.8 -0.4 -1.8% 0.02 0.688
Lifestyle without SMS 18.8 21.5 +2.6 +14.0% 0.44 <0.001
Lifestyle with SMS 19.5 21.7 +2.2 +11.2% 0.36 0.002
Body image (FNAE) Care as usual (CAU) 15.5 14.6 -0.9 -5.5% -0.12 0.447
Lifestyle without SMS 18.9 15.4 -3.5 -18.5% -0.50 0.001
Lifestyle with SMS 18.1 14.8 -3.3 -18.1% -0.47 0.008
https://doi.org/10.1371/journal.pone.0233876.t003
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Fig 3. Self-esteem scores over time.
https://doi.org/10.1371/journal.pone.0233876.g003
Fig 4. Body image scores over time.
https://doi.org/10.1371/journal.pone.0233876.g004
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especially where group members have similar backgrounds [54]. Other researchers have found
that, especially for women with PCOS, group support is important for behavior change and
reducing social isolation [55, 56]. The combination of small group treatment and one-year
treatment seems beneficial for this group of women with PCOS beyond weight loss.
A strength of the current study is that we started with a population that was not severely
depressed, whereas other researchers only either included [56] or excluded [57–59] severely
depressed patients. [57–59]. Many LS programmes have excluded participants with symptoms
of depression based on the idea that they may lose less weight than non-depressed participants
[57–59]. Hence, our population might be a reliable reflection of the clinical situation where a
substantial number of women with PCOS report moderate depressive symptoms [8]. It has
also been suggested that depressed participants should be identified before entering an LS
intervention and offered treatment for depression before entering an LS intervention [60].
Based on our findings, we consider that all women with PCOS, depressed or not depressed,
can benefit from a three-component LS intervention. Moreover, in particular, participants
with elevated depression scores at baseline should be selected for these interventions, since
they can benefit the most from lifestyle treatment.
A limitation of our study lies in the high discontinuation rates we observed in all arms of
the study. Compliance and drop-out are the most difficult aspects of any weight-reduction
intervention, especially in programmes that last over 42 weeks [61]. In general weight loss pro-
grammes, dropout rates of around 40% are observed [40]. We expected to have relatively high
discontinuation rates for two reasons: firstly, the intervention is demanding for participants
(the intervention takes place on Monday afternoons and involves a one-year commitment)
and secondly, because pregnancy, which is the ultimate goal for all participants, is considered
as a reason to end study participation. Because high drop-out rates were expected in this inter-
vention, a statistical method was chosen that could include all available data without imputa-
tion. Hence participants without a complete follow-up could also be included. This method
also compensated for selective dropout, on the condition that dropout is related to variables
included in the model [41].
Future research should examine whether the current LS programme could be further
improved with more PCOS-related topics and/or specific CBT sessions about depressive
Fig 5. Mediation effects.
https://doi.org/10.1371/journal.pone.0233876.g005
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thoughts. We have implemented the 3-component lifestyle intervention as standard care at
our outpatient clinic to contribute to this development. Weight loss and depression are the
biggest health concerns of women diagnosed with PCOS [62]. Based on their experiences,
most women are not satisfied with the emotional support and help they receive [12, 62]. Thus,
we believe that a three-component lifestyle programme should be accessible for all women
with PCOS who are overweight or obese and trying to become pregnant. Three-component
lifestyle interventions can contribute to a healthier weight, a better mood, and can enhance
self-esteem and body image in women with PCOS.
Conclusions
A three-component LS intervention programme with or without additional SMS resulted in
significant improvements in depression and self-esteem compared to CAU in women with
PCOS, obesity, and a wish to achieve a pregnancy. Testosterone, androstenedione, DHEA,
insulin, HOMA-IR, and cortisol did not mediate this effect. Weight loss mediated the effects
on self-esteem but not on depression and body-image. This suggests that LS treatment inde-
pendent of weight loss can reduce depression and body-image, whereas both LS treatment and
weight loss can improve self-esteem. Hence, a three-component lifestyle intervention based on
CBT can be successful in improving mood in women with PCOS who are overweight or obese
and attempting to become pregnant.
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